Lurasidone Hydrochloride
Showing 51 - 75 of 1,837
Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick
Active, not recruiting
- Ann Arbor Stage III Non-Hodgkin Lymphoma
- +2 more
- Cyclophosphamide
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 28, 2023
Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
Sep 20, 2022
Schizophrenia Trial in China (Lurasidone tablets, Risperidone tablets)
Completed
- Schizophrenia
- Lurasidone tablets
- Risperidone tablets
-
Beijing, Beijing, China
- +14 more
Nov 3, 2019
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide
- Metformin Hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 4, 2022
Pain Trial (Advil PM Liqui-Gels Minis, Advil PM Liqui-Gels)
Not yet recruiting
- Pain
- Advil PM Liqui-Gels Minis
- Advil PM Liqui-Gels
- (no location specified)
Jan 5, 2023
ADHD, ADHD Trial in Irvine (Methylphenidate Hydrochloride Extended Release Capsules, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- ADHD
- Methylphenidate Hydrochloride Extended Release Capsule
- Placebo
-
Irvine, CaliforniaUniversity of California, Irvine/Child Development Center
Nov 16, 2022
Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,
Completed
- Adult Angiosarcoma
- +3 more
- pazopanib hydrochloride
- +4 more
-
Chicago, Illinois
- +4 more
Jul 26, 2022
DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- Mitoxantrone Hydrochloride Liposome Injection
-
Jinan, Shandong, ChinaAffiliated Cancer Hospital of Shandong First Medical University
May 16, 2023
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Advanced Cancers Trial in Houston (Temsirolimus, Metformin)
Active, not recruiting
- Advanced Cancers
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)
Recruiting
- Interstitial Lung Diseases
- Anlotinib
- Placebo
-
Wenzhou, Zhejiang, ChinaThe First Affiliated Hospital of Wenzhou Medical University
Apr 13, 2023
Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)
Not yet recruiting
- Relapsed Small Cell Lung Cancer
- Irinotecan hydrochloride liposome Injection
- Topotecan
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023
Advanced Breast Cancer Trial in Shijiazhuang (Doxorubicin HCl liposome injection)
Completed
- Advanced Breast Cancer
- Doxorubicin hydrochloride liposome injection
-
Shijiazhuang, ChinaThe Fourth Hospital of Hebei Medical University
Oct 18, 2023
Relapsed/Refractory Multiple Myeloma Trial in Suzhou (Mitoxantrone HCl liposome/Dexamethasone/daratumumab)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
-
Suzhou, Jiangsu, ChinaSecond Affiliated Hospital of Soochow University
May 4, 2023
MDD (MDD) Trial (Ammoxetine, Placebo)
Not yet recruiting
- Major Depressive Disorder (MDD)
- Ammoxetine
- Placebo
- (no location specified)
Feb 28, 2023
Gastric Cancer Trial in Xi'an (Penpulimab combined with Anlotinib Hydrochloride Capsules and chemo;Cadonilimab combined with
Not yet recruiting
- Gastric Cancer
- Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Air Force Military Medical Univ
Mar 23, 2023
Generalized Anxiety Disorder Trial in Beijing (Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg,
Not yet recruiting
- Generalized Anxiety Disorder
- Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg
- +2 more
-
Beijing, ChinaPeking University Sixth Hospital
Aug 1, 2023
Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)
Completed
- Metastatic Cancer
- Unspecified Adult Solid Tumor
- PARP inhibitor BMN-673
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 22, 2022
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023
Erectile Dysfunction Trial in Peking (Tunodafil Hydrochloride Tablets, Placebo, Alcohol)
Completed
- Erectile Dysfunction
- Tunodafil Hydrochloride Tablets
- +2 more
-
Peking, ChinaPeking University People's Hospital
Jul 28, 2023
Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,
Active, not recruiting
- Colon Adenocarcinoma
- +18 more
- Cetuximab
- +5 more
-
Anchorage, Alaska
- +797 more
Jan 9, 2023